Barely Significant
← all excerpts

Optimal duration of adjuvant endocrine therapy: how to apply the newest data.

Ther Adv Med Oncol · 2017 · PMC5764154 · PMID 29344105

Europe PMCDOI
1
hedged sentence
0.0480
closest p · 1.0× alpha
0.0480
boldest claim

The sentences

did not reach statistical significancep = 0.048actually significant
In contrast with the findings of the MA.17R trial, the difference in DFS between control and placebo group did not reach statistical significance [7-year DFS 84.7 versus 81.3%, HR 0.85 (0.73–0.999), p = 0.048, statistical significance level 0.0418].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.